EUVIMEDEUVIMED entdecken
Fallbericht

CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report

Blair Hoeting, Kai Conrad Cecil Johnson

Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)

DOI: 10.6004/jnccn.2025.7289 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Blair Hoeting und 1 weiteren Autor:innen. Beteiligte Einrichtung: 1The Ohio State University - College of Medicine, Columbus, OH.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • 1The Ohio State University - College of Medicine, Columbus, OH.
  • 2The Ohio State University - James Comprehensive Cancer Center, Columbus, OH.

Zitieren

APA

Hoeting, B., & Johnson, K. C. C. (2026). CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7289

Vancouver

Hoeting B, Johnson KCC. CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7289

BibTeX
@article{Hoeting2026,
  author = {Hoeting, Blair and Johnson, Kai Conrad Cecil},
  title = {CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {3.5},
  doi = {10.6004/jnccn.2025.7289}
}
Kostenlos starten →